A Study to assess prognostic score in rectal cancer.
- Conditions
- Health Condition 1: - Health Condition 2: C189- Malignant neoplasm of colon, unspecified
- Registration Number
- CTRI/2020/01/022968
- Lead Sponsor
- Kastruba Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients of Rectal Cancer that require Neoadjuvant Chemotherapy
T3/T4 Tumours
T1/T2 with node involvement
Mesorectal Fascia involvement
2.Perfomance score 0-2 ECOG
3.Provides a voluntry informed consent to participate in the study
1.Metastatic disease at presentation.
2. history of radiotherapy for rectal cancers or other cancers of the pelvic region.
3.Patients receiving short course RT.
4.Relative contraindications to pelvic radiotherapy like presence of connective tissue disorders or irritable bowel syndrome/inflammatory bowel disease.
5. Patients not having adequate pre radiotherapy staging assessment like MRI.
6. Unfit or contraindicated to receive concurrent systemic chemotherapy due to presence of comorbidities, known allergy, etc.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method